These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1141 related articles for article (PubMed ID: 21864295)
1. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327 [TBL] [Abstract][Full Text] [Related]
3. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
4. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma]. Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213 [TBL] [Abstract][Full Text] [Related]
5. [Methylation pattern of DNA repair genes and microsatellite instability in hepatocelluar carcinoma]. Park JH; Cho SB; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Lee JH; Kim SJ Korean J Gastroenterol; 2006 Nov; 48(5):327-36. PubMed ID: 17132921 [TBL] [Abstract][Full Text] [Related]
6. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118 [TBL] [Abstract][Full Text] [Related]
7. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213 [TBL] [Abstract][Full Text] [Related]
8. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells]. Meng CF; Zhu XJ; Dai DQ; Peng G Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):494-7. PubMed ID: 19742343 [TBL] [Abstract][Full Text] [Related]
9. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789 [TBL] [Abstract][Full Text] [Related]
11. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma. Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer. Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174 [TBL] [Abstract][Full Text] [Related]
16. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer. Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668 [TBL] [Abstract][Full Text] [Related]
17. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma. Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688 [TBL] [Abstract][Full Text] [Related]
18. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP]. Meng CF; Dai DQ; Guo KJ Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988 [TBL] [Abstract][Full Text] [Related]